Rapid genotyping of the G534E polymorphism (Marburg I) of the gene encoding the factor VII-activating protease (FSAP) by LightCycler PCR

Clinical Biochemistry

Volumn 40, Issue 13-14, 2007, Pages 1063-1064

  Tag, Carmen G ^a   Mengsteab, Senait ^a   Kanse, Sandip M ^b   Weiskirchen, Ralf ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; DIMETHYL SULFOXIDE; FACTOR VII ACTIVATING PROTEASE; GUANINE; MAGNESIUM CHLORIDE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; CELL PROLIFERATION; DNA DETERMINATION; DNA POLYMORPHISM; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC RISK; GENOTYPE; HUMAN; INTIMA; LETTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THROMBOEMBOLISM; VASCULAR SMOOTH MUSCLE;

BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; SERINE ENDOPEPTIDASES;

EID: 34548138827     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.05.007     Document Type: Letter

References (9)

1. Roemisch J., Feussner A., Nerlich C., et al. The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP). Blood Coagul. Fibrinolysis 13 (2002) 433-441
2. Sedding D., Daniel J.M., Muhl L., et al. The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation. J. Exp. Med. 203 (2006) 2801-2807
3. Willeit J., Kiechl S., Weimer T., et al. Marburg I polymorphism of factor VII-activating protease: a prominent risk predictor of carotid stenosis. Cir culation 107 (2003) 667-670
4. Ireland H., Miller G.J., Webb K.E., et al. The factor VII activating protease G511E (Marburg) variant and cardiovascular risk. Thromb. Haemost. 92 (2004) 986-992
5. Hoppe B., Tolou F., Radtke H., et al. Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism. Blood 105 (2005) 1549-1551
6. van Minkelen R., de Visser M.C., Vos H.L., et al. The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis. Blood 105 (2005) 4898
7. Franchi F., Martinelli I., Biguzzi E., et al. Marburg I polymorphism of factor VII-activating protease and risk of venous thromboembolism. Blood. 107 (2006) 1731
8. Hoppe B., Dorner T., Kiesewetter H., et al. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb. Haemost. 95 (2006) 907-908
9. Gulesserian T., Hron G., Endler G., et al. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb. Haemost. 95 (2006) 65-67